Kenvue Inc. (KVUE)

NYSE: KVUE · IEX Real-Time Price · USD
19.58
0.00 (0.00%)
At close: Apr 22, 2024, 4:00 PM
19.61
+0.03 (0.15%)
After-hours: Apr 22, 2024, 7:58 PM EDT
0.00%
Market Cap 37.49B
Revenue (ttm) 15.44B
Net Income (ttm) 1.66B
Shares Out 1.91B
EPS (ttm) 0.90
PE Ratio 21.76
Forward PE 16.78
Dividend $0.80 (4.09%)
Ex-Dividend Date Feb 13, 2024
Volume 16,776,663
Open 19.58
Previous Close 19.58
Day's Range 19.18 - 19.71
52-Week Range 17.82 - 27.80
Beta n/a
Analysts Buy
Price Target 24.69 (+26.1%)
Earnings Date May 7, 2024

About KVUE

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Ma... [Read more]

IPO Date May 4, 2023
Employees 22,000
Stock Exchange NYSE
Ticker Symbol KVUE
Full Company Profile

Financial Performance

In 2023, Kenvue's revenue was $15.44 billion, an increase of 3.30% compared to the previous year's $14.95 billion. Earnings were $1.66 billion, a decrease of -19.38%.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for KVUE stock is "Buy." The 12-month stock price forecast is $24.69, which is an increase of 26.10% from the latest price.

Price Target
$24.69
(26.10% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Court Orders Johnson & Johnson And Kenvue To Pay $45 Million In Talcum Baby Powder Lawsuit

An Illinois court late Friday ordered pharmaceutical giant Johnson & Johnson and Kenvue to pay $45 million to a family that alleged the companies' talcum-based baby powder led to the death of a relati...

Other symbols: JNJ
2 days ago - Forbes

Here's why Harris' Alex Fitch favors Kenvue

Alex Fitch, Harris Associates director of U.S. Research, joins 'Money Movers' to discuss Fitch's investment thesis towards Delta Air Lines, whether investors are not supposed to buy cyclical stocks at...

12 days ago - CNBC Television

Kenvue to Announce First Quarter 2024 Results on May 7, 2024

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue, the world's largest pure-play consumer health company by revenue, will announce its 2024 Q1 results before market open on May 7, 2024.

17 days ago - Business Wire

Kenvue to Showcase 22 New Sets of Clinical Data at American Academy of Dermatology Association Meeting

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. will share new data at the American Academy of Dermatology (AAD) Association Annual Meeting.

6 weeks ago - Business Wire

David Einhorn's Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy

David Einhorn's hedge fund Greenlight Capital picked up a new stake in Kenvue Inc. KVUE — formerly the consumer healthcare division of Johnson & Johnson JNJ — in the fourth quarter, according to a pub...

Other symbols: SWNGLD
2 months ago - Market Watch

Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue CEO and CFO to present at the Consumer Analyst Group of New York (CAGNY) Conference on February 23, 2024 at 10 a.m. EST.

2 months ago - Business Wire

J&J spinoff Kenvue stock loses ground as profit drops

Kenvue Inc.'s stock KVUE, -0.39% fell by 3.2% in premarket trading on Thursday after the household products spin-off of Johnson & Johnson JNJ, -0.05% reported lower fourth-quarter profit and said its ...

2 months ago - Market Watch

Tylenol maker Kenvue forecasts annual profit below estimates after weak quarter

Kenvue forecast full-year profit below analysts' expectations after missing quarterly sales estimates on Thursday, as the Tylenol maker faces sluggish demand in China and slowing growth for skin and b...

2 months ago - Reuters

Kenvue Reports Full Year and Fourth Quarter 2023 Results

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”), today announced financial results for the fiscal full year and fourth quarter ended December 31, 2023.

2 months ago - Business Wire

3 Top Value Stocks to Buy and Hold for 2024

These high-quality companies are solid—and their stocks look cheap.

Other symbols: CPBGILD
2 months ago - Morningstar

Kenvue Declares Quarterly Cash Dividend

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue today announced that its Board of Directors has declared a dividend payable in Q1 of $0.20 per share on the Company's common stock.

3 months ago - Business Wire

3 Dividend Stocks for January 2024

The dividend prospects of three firms with wide or narrow Morningstar Economic Moat Ratings.

Other symbols: LMTMS
3 months ago - Morningstar

Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024

SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce financial results for the fourth quarter and full year ending December 31, 2023, on February 8, 2024.

3 months ago - Business Wire

Lawsuits claiming Tylenol causes autism lack scientific support, judge finds

Dec 19 (Reuters) - A judge has barred expert witnesses from testifying that Johnson & Johnson (JNJ.N) spin-off Kenvue's (KVUE.N) painkiller Tylenol can cause autism if mothers take it during pregnancy...

4 months ago - Reuters

Kenvue Shares Are Rising. Tylenol Litigation Fades Into the Rearview.

A ruling hurts litigation against Kenvue that alleges a link between prenatal exposure to the company's Tylenol and autism spectrum disorder or ADHD.

4 months ago - Barrons

Kenvue shares rise after favorable court ruling in Tylenol litigation

Shares of Tylenol maker Kenvue Inc. KVUE, +0.10% gained more than 5% premarket on Tuesday after a federal court judge in New York ruled that plaintiffs' expert testimony will be blocked in a case invo...

4 months ago - Market Watch

Kenvue: A High-Quality Consumer Health Company on Sale

In May, Kenvue Inc. (KVUE, Financial) successfully concluded its separation from Johnson & Johnson (JNJ, Financial); however, its stock has experienced a decline about 25% since the completion of this...

4 months ago - GuruFocus

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "t...

4 months ago - Accesswire

KVUE DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important December 8 Deadline in Securities Class Action Commenced by the Firm – KVUE

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kenvue Inc. (NYSE: KVUE) pursuant and/or traceable to the registration statem...

4 months ago - Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc. (KVUE)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 8, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of invest...

4 months ago - Business Wire

FINAL DEADLINE REMINDER FOR KVUE INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead Plaintiff Deadline in Securities Class Action Lawsuit Filed Against Kenvue Inc. (KVUE)

RADNOR, Pa. , Dec. 7, 2023 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Kenvue Inc....

4 months ago - PRNewsWire

KVUE Investors Have Opportunity to Lead Kenvue Inc. Securities Fraud Lawsuit

BENSALEM, Pa. , Dec. 6, 2023 /PRNewswire/ -- Law Offices of Howard G.

4 months ago - PRNewsWire

DECEMBER 8 DEADLINE: The Schall Law Firm Encourages Investors in Kenvue Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kenvue Inc. ("Kenvue" or "t...

4 months ago - Accesswire

KENVUE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Kenvue To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 investing in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") iss...

4 months ago - PRNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Kenvue Inc.(KVUE) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Dec. 5, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Kenvue Inc. ("Kenvue" or the "Company") (NYSE: KVUE) of a class action securities lawsuit. CLASS DEFINITION: The law...

4 months ago - PRNewsWire